TPG, CPPIB and Leonard Green owned IMS Health to go public on NYSE
IMS Health Holding Inc., the ultimate parent company of IMS Health Incorporated, has filed for a proposed initial public offering (IPO).
IMS Health intends to list its share on the New York Stock Exchange (NYSE) under the symbol “IMS.”
J.P. Morgan Securities, Goldman, Sachs & Co. and Morgan Stanley & Co. are acting as joint book-running managers of the underwriting syndicate that also includes Merrill Lynch, Pierce, Fenner & Smith, Barclays Capital, Deutsche Bank Securities and Wells Fargo Securities.
On February 26, 2010, TPG Capital, CPP Investment Board (CPPIB) and Leonard Green & Partners took IMS Health (formerly NYSE: RX) private for $5.2 billion. TPG, CPPIB and Leonard Green invested approximately $912 million in equity to privatize IMS.
TPG, CPPIB and Leonard Green currently own 98.92% of IMS outstanding shares or 98.16% on fully diluted basis.
In September 2013, IMS Health acquired the assets of Diversinet Corp. (formerly TSX-V: DIV; OTC QB: DVNTF) for $3.5 million.